Research Topics
Genomes and Genes
| Motohiko SatoSummaryAffiliation: Yokohama City University Location: Yokohama, Japan Publications
| Collaborators
|
Detail Information
Publications
Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive ratsM Sato
First Department of Internal Medicine, Asahikawa Medical College, Japan
Am J Hypertens 8:160-6. 1995..This abnormal responsiveness to TGF-beta 1 is involved in the proliferative characteristics of SHR-VSMC. Therefore, TGF-beta 1 could contribute to the development of hypertension or vascular hypertrophy in SHR...
Identification of transcription factor E3 (TFE3) as a receptor-independent activator of Gα16: gene regulation by nuclear Gα subunit and its activatorMotohiko Sato
Cardiovascular Research Institute, Yokohama City University School of Medicine, Fukuura, Yokohama 236 0004, Japan
J Biol Chem 286:17766-76. 2011..These findings indicate that TFE3 and Gα(16) are up-regulated under pathologic conditions and are involved in a novel mechanism of transcriptional regulation via the relocalization and activation of Gα(16)...
Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosusUtako Yokoyama
Department of Life Science and Medical Bioscience, Waseda University Graduate School of Advanced Science and Engineering, 2 2, Wakamatsu cho, TWIns, Shinjuku ku, Tokyo 162 8480, Japan
Circ Res 106:1882-92. 2010..After birth, however, differential regulation of vasodilation and IT is preferable for treatment of patients with patent DA and DA-dependent congenital cardiac malformations...
Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes: role of G betagamma and connexin 43 (CX43)Motohiko Sato
Cardiovascular Research Institute, Yokohama City University School of Medicine, Fukuura, Yokohama 236 0004, Japan
J Biol Chem 284:31431-40. 2009..Under hypoxic stress, this unrecognized response program plays a critical role in the fate of NCM...
Accessory proteins for heterotrimeric G-protein: Implication in the cardiovascular systemMotohiko Sato
Cardiovascular Research Institute, Yokohama City University, School of Medicine, 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
Pathophysiology 17:89-99. 2010..Such information may contribute to uncovering mechanisms underlying cardiovascular disease as well as the development of novel therapeutic approaches to human disease...
Signaling by a non-dissociated complex of G Protein betagamma and alpha subunits stimulated by a receptor-independent activator of G protein signaling, AGS8Chujun Yuan
Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Biol Chem 282:19938-47. 2007..These data implicate a mechanism for AGS8, and potentially other Gbetagamma binding proteins, for directing Gbetagamma signaling through alternative effector activation sites on Gbetagamma in the absence of subunit dissociation...
Identification and characterization of a G-protein regulatory motif in WAVE1Kyoung Seob Song
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112, USA
FEBS Lett 580:1993-8. 2006..The docking of Gialpha within a WAVE1 scaffolding complex may facilitate dynamic cycling and/or targeting for efficient and localized control of actin polymerization...
Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with GbetagammaMotohiko Sato
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
Proc Natl Acad Sci U S A 103:797-802. 2006..Mechanistically, AGS8 appears to promote G protein signaling by a previously unrecognized mechanism that involves direct interaction with Gbetagamma...
Accessory proteins for G proteins: partners in signalingMotohiko Sato
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
Annu Rev Pharmacol Toxicol 46:151-87. 2006..AGS and related accessory proteins reveal unexpected diversity in G protein subunits as signal transducers within the cell...
AGS proteins: receptor-independent activators of G-protein signalingJoe B Blumer
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
Trends Pharmacol Sci 26:470-6. 2005..Thus, these proteins and the concepts advanced with their discovery highlight the diversity associated with G-protein signaling and present new avenues for the development of therapeutics that target G-protein signaling...
Identification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of GialphaXiaoqing Cao
The Guthrie Research Institute, Sayre, Pennsylvania 18840, USA
J Biol Chem 279:27567-74. 2004....
AGS3 and signal integration by Galpha(s)- and Galpha(i)-coupled receptors: AGS3 blocks the sensitization of adenylyl cyclase following prolonged stimulation of a Galpha(i)-coupled receptor by influencing processing of Galpha(i)Motohiko Sato
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
J Biol Chem 279:13375-82. 2004....
Pertussis toxin-insensitive activation of the heterotrimeric G-proteins Gi/Go by the NG108-15 G-protein activatorCatalina Ribas
Centro de Biologia Molecular, Severo Ochoa (CSIC-UAM, Universidad Autonoma de Madrid, Cantoblanco, 28049-Madrid, Spain
J Biol Chem 277:50223-5. 2002..These data indicate the presence of unexpected regulatory domains on G(i)/G(o) proteins and suggest the existence of pertussis toxin-insensitive modes of signal input to G(i)/G(o) signaling systems...
Analysis of signal transfer from receptor to Go/Gi in different membrane environments and receptor-independent activators of brain G proteinCatalina Ribas
, , Cantoblanco, 28049 Madrid, Spain
Methods Enzymol 344:140-52. 2002
Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cellsJ Zhang
Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425, USA
Am J Physiol 273:H971-80. 1997....
Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclaseA Marjamaki
Department of Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Biol Chem 272:16466-73. 1997..These data indicate that the integration of multiple signals by adenylyl cyclases is a dynamic process depending upon the enzyme type and phosphorylation status...
Characterization of a G-protein activator in the neuroblastoma-glioma cell hybrid NG108-15M Sato
Department of Pharmacology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Biol Chem 271:30052-60. 1996..The G-protein activator was distinct from other proteins (neuromodulin, tubulin, and beta-amyloid precursor protein) that influence nucleotide binding to G-protein, indicating the existence of a novel signal accelerator...
Factors determining specificity of signal transduction by G-protein-coupled receptors. Regulation of signal transfer from receptor to G-proteinM Sato
Department of Pharmacology, Medical University of South Carolina, Charleston 29425, USA
J Biol Chem 270:15269-76. 1995..These data indicate that the transfer of signal from R to G is regulated by a cell type-specific, membrane-associated protein that enhances the agonist-induced activation of G...
The roles of cytochrome p450 in ischemic heart diseaseMotohiko Sato
Cardiovascular Research Institute, Yokohama City University School of Medicine, Fukuura, Kanazawa Ku, Japan
Curr Drug Metab 12:526-32. 2011..In this review, we summarize current knowledge of this enzyme family and discuss the roles of CYP in ischemia-reperfusion injury of the heart...
